[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK2649101T3 - Fremgangsmåde til fremstilling af en tværbundet gel - Google Patents

Fremgangsmåde til fremstilling af en tværbundet gel Download PDF

Info

Publication number
DK2649101T3
DK2649101T3 DK11799874.0T DK11799874T DK2649101T3 DK 2649101 T3 DK2649101 T3 DK 2649101T3 DK 11799874 T DK11799874 T DK 11799874T DK 2649101 T3 DK2649101 T3 DK 2649101T3
Authority
DK
Denmark
Prior art keywords
counted
gel
preparing
procedure
cross
Prior art date
Application number
DK11799874.0T
Other languages
English (en)
Inventor
Stéphane Meunier
François Bourdon
Original Assignee
Teoxane
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44265691&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2649101(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teoxane filed Critical Teoxane
Application granted granted Critical
Publication of DK2649101T3 publication Critical patent/DK2649101T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G59/00—Polycondensates containing more than one epoxy group per molecule; Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • C08J3/075—Macromolecular gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
    • C08J2305/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Dermatology (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
DK11799874.0T 2010-12-06 2011-12-06 Fremgangsmåde til fremstilling af en tværbundet gel DK2649101T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1060135A FR2968305B1 (fr) 2010-12-06 2010-12-06 Procede de preparation d'un gel reticule
PCT/IB2011/055495 WO2012077054A1 (en) 2010-12-06 2011-12-06 Process of preparing a cross linked gel

Publications (1)

Publication Number Publication Date
DK2649101T3 true DK2649101T3 (da) 2021-08-16

Family

ID=44265691

Family Applications (1)

Application Number Title Priority Date Filing Date
DK11799874.0T DK2649101T3 (da) 2010-12-06 2011-12-06 Fremgangsmåde til fremstilling af en tværbundet gel

Country Status (14)

Country Link
US (1) US9393189B2 (da)
EP (1) EP2649101B1 (da)
JP (1) JP5860060B2 (da)
KR (1) KR101868183B1 (da)
AU (1) AU2011340106B2 (da)
BR (1) BR112013012251B1 (da)
CA (1) CA2817837C (da)
DK (1) DK2649101T3 (da)
ES (1) ES2883135T3 (da)
FR (1) FR2968305B1 (da)
PL (1) PL2649101T3 (da)
PT (1) PT2649101T (da)
RU (1) RU2590558C2 (da)
WO (1) WO2012077054A1 (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2818184B1 (en) 2007-11-16 2018-10-31 Allergan, Inc. Compositions and methods for treating Purpura
US8394782B2 (en) 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having increased longevity
US8450475B2 (en) 2008-08-04 2013-05-28 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
CA2735173C (en) 2008-09-02 2017-01-10 Tautona Group Lp Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof
FR2945293B1 (fr) * 2009-05-11 2011-06-17 Teoxane Procede de preparation d'un gel reticule.
US20110172180A1 (en) 2010-01-13 2011-07-14 Allergan Industrie. Sas Heat stable hyaluronic acid compositions for dermatological use
CA2792729C (en) 2010-03-12 2016-06-28 Allergan Industrie, Sas Fluid compositions for improving skin conditions
CA2794254C (en) 2010-03-22 2018-09-04 Allergan, Inc. Polysaccharide and protein-polysaccharide cross-linked hydrogels for soft tissue augmentation
US9005605B2 (en) 2010-08-19 2015-04-14 Allergan, Inc. Compositions and soft tissue replacement methods
US8883139B2 (en) 2010-08-19 2014-11-11 Allergan Inc. Compositions and soft tissue replacement methods
US8889123B2 (en) 2010-08-19 2014-11-18 Allergan, Inc. Compositions and soft tissue replacement methods
US20130096081A1 (en) 2011-06-03 2013-04-18 Allergan, Inc. Dermal filler compositions
US9408797B2 (en) 2011-06-03 2016-08-09 Allergan, Inc. Dermal filler compositions for fine line treatment
ES2738208T3 (es) 2011-06-03 2020-01-20 Allergan Ind Sas Composiciones de relleno dérmico que incluyen antioxidantes
US9393263B2 (en) 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
US20130244943A1 (en) 2011-09-06 2013-09-19 Allergan, Inc. Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
US9662422B2 (en) 2011-09-06 2017-05-30 Allergan, Inc. Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
EP3620184A1 (en) 2014-09-30 2020-03-11 Allergan Industrie, SAS Stable hydrogel compositions including additives
FR3029928B1 (fr) 2014-12-15 2018-03-09 Teoxane Gel reticule
FR3034195B1 (fr) * 2015-03-24 2017-04-21 Teoxane Procede d'evaluation des performances mecaniques d'un gel de comblement
FR3066386B1 (fr) * 2017-05-18 2020-08-28 Bioxis Pharmaceuticals Procede de preparation d'un gel aqueux d'acide hyaluronique
US20220193116A1 (en) 2018-02-06 2022-06-23 Regen Lab Sa Cross-linked hyaluronic acids and combinations with prp/bmc
KR20200046649A (ko) 2018-10-25 2020-05-07 (주)뉴크레이티브랩 혼합상 히알루론산 제조방법
FR3146900A1 (fr) 2023-03-21 2024-09-27 Teoxane SA Procédé de préparation d’un hydrogel stérile comprenant un polysaccharide réticulé, non réticulé ou leur mélange
FR3146899A1 (fr) 2023-03-21 2024-09-27 Teoxane SA Procédé de préparation d’un hydrogel stérile comprenant un polysaccharide réticulé, non réticulé ou leur mélange

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9902652D0 (en) * 1999-02-05 1999-03-31 Fermentech Med Ltd Process
FR2811996B1 (fr) 2000-07-19 2003-08-08 Corneal Ind Reticulation de polysaccharide(s), preparation d'hydrogel(s) ; polysaccharide(s) et hydrogel(s) obtenus,leurs utilisations
TW574301B (en) 2001-05-02 2004-02-01 Ind Tech Res Inst Manufacturing method of epoxide crosslinked polysaccharides matrix
DE10223310A1 (de) 2002-05-24 2003-12-11 Biotronik Mess & Therapieg Verfahren zum Beschichten von Implantaten mit einer Polysaccharid-Lage
TWI251596B (en) * 2002-12-31 2006-03-21 Ind Tech Res Inst Method for producing a double-crosslinked hyaluronate material
FR2861734B1 (fr) 2003-04-10 2006-04-14 Corneal Ind Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
US8524213B2 (en) 2003-12-30 2013-09-03 Genzyme Corporation Polymeric materials, their preparation and use
FR2865737B1 (fr) 2004-02-03 2006-03-31 Anteis Sa Gel reticule biocompatible
US20050226936A1 (en) * 2004-04-08 2005-10-13 Q-Med Ab Method of soft tissue augmentation
WO2005112888A2 (en) 2004-05-20 2005-12-01 Mentor Corporation Methods for making injectable polymer hydrogels
US20060105022A1 (en) 2004-11-15 2006-05-18 Shiseido Co., Ltd. Process for preparing crosslinked hyaluronic acid gel
JP4875988B2 (ja) * 2004-11-15 2012-02-15 株式会社 資生堂 架橋ヒアルロン酸ゲルの製造方法
DK1817347T3 (da) 2004-11-24 2017-08-14 Albumedix As Fremgangsmåde til Tværbinding af Hyaluronsyre med Divinylsulfon
CN101153061A (zh) 2006-09-29 2008-04-02 北京普麦迪克生物技术研究所 一种透明质酸及其二次交联形成凝胶的方法
FR2908775B1 (fr) * 2006-11-17 2012-08-31 Biomatlante Hydrogel et ses applications biomedicales
JP5071766B2 (ja) 2006-12-08 2012-11-14 独立行政法人日本原子力研究開発機構 多糖類を原料とするゲルの製造方法
FR2924615B1 (fr) * 2007-12-07 2010-01-22 Vivacy Lab Hydrogel cohesif biodegradable.
US8450475B2 (en) 2008-08-04 2013-05-28 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
NO2236523T3 (da) 2009-03-30 2018-07-21
FR2945293B1 (fr) 2009-05-11 2011-06-17 Teoxane Procede de preparation d'un gel reticule.
IT1395392B1 (it) 2009-08-27 2012-09-14 Fidia Farmaceutici Geli viscoelastici come nuovi filler
NZ610346A (en) 2010-11-08 2015-06-26 Allergan Ind Sas Hyaluronic acid based formulations

Also Published As

Publication number Publication date
ES2883135T3 (es) 2021-12-07
BR112013012251A2 (pt) 2016-08-09
PL2649101T3 (pl) 2021-11-22
FR2968305B1 (fr) 2014-02-28
CA2817837A1 (en) 2012-06-14
RU2590558C2 (ru) 2016-07-10
US20130237615A1 (en) 2013-09-12
FR2968305A1 (fr) 2012-06-08
KR20130132510A (ko) 2013-12-04
PT2649101T (pt) 2021-08-05
EP2649101A1 (en) 2013-10-16
JP2013544944A (ja) 2013-12-19
AU2011340106B2 (en) 2016-03-03
AU2011340106A1 (en) 2013-06-06
KR101868183B1 (ko) 2018-06-15
WO2012077054A1 (en) 2012-06-14
RU2013125786A (ru) 2015-01-20
US9393189B2 (en) 2016-07-19
CA2817837C (en) 2019-07-09
BR112013012251B1 (pt) 2021-02-09
EP2649101B1 (en) 2021-06-02
JP5860060B2 (ja) 2016-02-16

Similar Documents

Publication Publication Date Title
DK2649101T3 (da) Fremgangsmåde til fremstilling af en tværbundet gel
DK2429486T3 (da) Fremgangsmåde til fremstilling af en tværbundet gel
DK3406337T3 (da) Fremgangsmåde til fremstilling af en hydrokrakningskatalysator
DK2467204T3 (da) Fremgangsmåde til fremstilling af en sorbent
DK2496562T3 (da) Fremgangsmåde til fremstilling af calcobutrol
DK2662352T3 (da) Fremgangsmåde til fremstilling af phenylacetamidforbindelse
DK2629975T3 (da) Anordninger til fremstilling af væv
DK2659675T3 (da) Fremgangsmåde for billedsegmentering under anvendelse af søjler
BR112013013263A2 (pt) conjunto de conexão
BR112013014989A2 (pt) completamento de poço
DK2595948T3 (da) Fremgangsmåde til fremstilling af ingenol-3-angelat
DK3104003T3 (da) Nacellekonstruktion til en vindmølle
DK3985979T3 (da) Fremgangsmåde til bestemmelse af referenceenhed
DK2430196T3 (da) Fremgangsmåde til fremstilling af alkoholer
DK2596099T3 (da) Fremgangsmåde til høst af ekspressionsprodukter
DK3275896T3 (da) Fremgangsmåde til at opnå antistoffer
DK2582283T3 (da) Fremgangsmåde til estimering af en referencestilling
DK2582416T3 (da) Holder til en injektionssprøjte
DK2424959T3 (da) Fremgangsmåde til fremstilling af en hydrokrakningskatalysator
DK2598479T3 (da) Fremgangsmåde til fremstilling af Ramipril
DK2444068T3 (da) Brimonidingelpræparat
DK2472055T3 (da) Værktøj til tilvejebringelse af kunstigt løft
DK2742017T3 (da) Fremgangsmåde til fremstilling af komplekser af 68ga
DK2616101T3 (da) Fremgangsmåde til oprensning af pegyleret erythropoietin
DK2872536T3 (da) Fremgangsmåde til ekstraktion af biomasse